MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
42.25
-1.26 (-2.90%)
Apr 18, 2024, 4:00 PM EDT - Market closed

MLTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
22.3223.0118.040.11
Research & Development
31.842.0535.530
Other Operating Expenses
0000
Operating Expenses
54.1265.0653.580.11
Operating Income
-54.12-65.06-53.58-0.11
Other Expense / Income
-10.14-0.590.06-0.01
Pretax Income
-43.98-64.47-53.64-0.09
Income Tax
0.090.0400
Net Income
-44.08-64.51-53.64-0.09
Shares Outstanding (Basic)
49292339
Shares Outstanding (Diluted)
49292339
Shares Change
67.30%-87.40%2510.73%-
EPS (Basic)
-0.73-1.70-230.15-0.01
EPS (Diluted)
-0.73-1.70-230.15-0.01
Free Cash Flow
-43.06-55.91-35.23-0.32
Free Cash Flow Per Share
-0.88-1.90-0.15-0.04
EBITDA
-43.97-64.46-53.63-0.09
Depreciation & Amortization
0.010.0100
EBIT
-43.98-64.47-53.64-0.09
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).